Robert Plenge, EVP & Chief Research Officer, BMS: Reinventing Drug Discovery
Sep 24, 2026 - 00:45:41
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to explore how bold platform bets, scalable cell therapies, and autoimmune breakthroughs could reshape medicine. Fred...
Related Episodes
Continue listening to more episodes from Biotech 2050 Podcast.
Nello Mainolfi, Founder, President & CEO, Kymera: Pioneering Targeted Protein Degradation
Sep 16, 2026 - 00:38:52
Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery
Aug 3, 2026 - 00:47:40
Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients
Jun 10, 2026 - 00:41:21
Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
May 13, 2026 - 00:33:34
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Apr 16, 2026 - 00:23:07
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Mar 6, 2026 - 00:14:16